Global Atropine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Atropine market size is predicted to grow from US$ 474 million in 2025 to US$ 426 million in 2031; it is expected to grow at a CAGR of -1.8% from 2025 to 2031.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Global Atropine key players include C?PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
LP Information, Inc. (LPI) ' newest research report, the “Atropine Industry Forecast” looks at past sales and reviews total world Atropine sales in 2024, providing a comprehensive analysis by region and market sector of projected Atropine sales for 2025 through 2031. With Atropine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atropine industry.
This Insight Report provides a comprehensive analysis of the global Atropine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atropine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Atropine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atropine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atropine.
This report presents a comprehensive overview, market shares, and growth opportunities of Atropine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Atropine market?
What factors are driving Atropine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atropine market opportunities vary by end market size?
How does Atropine break out by Type, by Application?
The global Atropine market size is predicted to grow from US$ 474 million in 2025 to US$ 426 million in 2031; it is expected to grow at a CAGR of -1.8% from 2025 to 2031.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Global Atropine key players include C?PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
LP Information, Inc. (LPI) ' newest research report, the “Atropine Industry Forecast” looks at past sales and reviews total world Atropine sales in 2024, providing a comprehensive analysis by region and market sector of projected Atropine sales for 2025 through 2031. With Atropine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atropine industry.
This Insight Report provides a comprehensive analysis of the global Atropine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atropine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Atropine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atropine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atropine.
This report presents a comprehensive overview, market shares, and growth opportunities of Atropine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Drop
- Gel
- Gastrointestinal
- Ophthalmology
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- C?PHARMA
- RESONANCE LABORATORIES
- ROLABO OUTSOURCING
- Minsheng
- CR Double-Crane
- HENAN PURUI
- Albany Molecular Research
- Alchem International
- SAURAV CHEMICALS
- Katsura Chemical
- Hangzhou Vega
- Wuhan senwayer century
What is the 10-year outlook for the global Atropine market?
What factors are driving Atropine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atropine market opportunities vary by end market size?
How does Atropine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Atropine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Atropine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Atropine by Country/Region, 2020, 2024 & 2031
2.2 Atropine Segment by Type
2.2.1 Injection
2.2.2 Drop
2.2.3 Gel
2.3 Atropine Sales by Type
2.3.1 Global Atropine Sales Market Share by Type (2020-2025)
2.3.2 Global Atropine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Atropine Sale Price by Type (2020-2025)
2.4 Atropine Segment by Application
2.4.1 Gastrointestinal
2.4.2 Ophthalmology
2.4.3 Other
2.5 Atropine Sales by Application
2.5.1 Global Atropine Sale Market Share by Application (2020-2025)
2.5.2 Global Atropine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Atropine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Atropine Breakdown Data by Company
3.1.1 Global Atropine Annual Sales by Company (2020-2025)
3.1.2 Global Atropine Sales Market Share by Company (2020-2025)
3.2 Global Atropine Annual Revenue by Company (2020-2025)
3.2.1 Global Atropine Revenue by Company (2020-2025)
3.2.2 Global Atropine Revenue Market Share by Company (2020-2025)
3.3 Global Atropine Sale Price by Company
3.4 Key Manufacturers Atropine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Atropine Product Location Distribution
3.4.2 Players Atropine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ATROPINE BY GEOGRAPHIC REGION
4.1 World Historic Atropine Market Size by Geographic Region (2020-2025)
4.1.1 Global Atropine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Atropine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Atropine Market Size by Country/Region (2020-2025)
4.2.1 Global Atropine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Atropine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Atropine Sales Growth
4.4 APAC Atropine Sales Growth
4.5 Europe Atropine Sales Growth
4.6 Middle East & Africa Atropine Sales Growth
5 AMERICAS
5.1 Americas Atropine Sales by Country
5.1.1 Americas Atropine Sales by Country (2020-2025)
5.1.2 Americas Atropine Revenue by Country (2020-2025)
5.2 Americas Atropine Sales by Type (2020-2025)
5.3 Americas Atropine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Atropine Sales by Region
6.1.1 APAC Atropine Sales by Region (2020-2025)
6.1.2 APAC Atropine Revenue by Region (2020-2025)
6.2 APAC Atropine Sales by Type (2020-2025)
6.3 APAC Atropine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Atropine by Country
7.1.1 Europe Atropine Sales by Country (2020-2025)
7.1.2 Europe Atropine Revenue by Country (2020-2025)
7.2 Europe Atropine Sales by Type (2020-2025)
7.3 Europe Atropine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Atropine by Country
8.1.1 Middle East & Africa Atropine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Atropine Revenue by Country (2020-2025)
8.2 Middle East & Africa Atropine Sales by Type (2020-2025)
8.3 Middle East & Africa Atropine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atropine
10.3 Manufacturing Process Analysis of Atropine
10.4 Industry Chain Structure of Atropine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Atropine Distributors
11.3 Atropine Customer
12 WORLD FORECAST REVIEW FOR ATROPINE BY GEOGRAPHIC REGION
12.1 Global Atropine Market Size Forecast by Region
12.1.1 Global Atropine Forecast by Region (2026-2031)
12.1.2 Global Atropine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Atropine Forecast by Type (2026-2031)
12.7 Global Atropine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 C?PHARMA
13.1.1 C?PHARMA Company Information
13.1.2 C?PHARMA Atropine Product Portfolios and Specifications
13.1.3 C?PHARMA Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 C?PHARMA Main Business Overview
13.1.5 C?PHARMA Latest Developments
13.2 RESONANCE LABORATORIES
13.2.1 RESONANCE LABORATORIES Company Information
13.2.2 RESONANCE LABORATORIES Atropine Product Portfolios and Specifications
13.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 RESONANCE LABORATORIES Main Business Overview
13.2.5 RESONANCE LABORATORIES Latest Developments
13.3 ROLABO OUTSOURCING
13.3.1 ROLABO OUTSOURCING Company Information
13.3.2 ROLABO OUTSOURCING Atropine Product Portfolios and Specifications
13.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ROLABO OUTSOURCING Main Business Overview
13.3.5 ROLABO OUTSOURCING Latest Developments
13.4 Minsheng
13.4.1 Minsheng Company Information
13.4.2 Minsheng Atropine Product Portfolios and Specifications
13.4.3 Minsheng Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Minsheng Main Business Overview
13.4.5 Minsheng Latest Developments
13.5 CR Double-Crane
13.5.1 CR Double-Crane Company Information
13.5.2 CR Double-Crane Atropine Product Portfolios and Specifications
13.5.3 CR Double-Crane Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CR Double-Crane Main Business Overview
13.5.5 CR Double-Crane Latest Developments
13.6 HENAN PURUI
13.6.1 HENAN PURUI Company Information
13.6.2 HENAN PURUI Atropine Product Portfolios and Specifications
13.6.3 HENAN PURUI Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HENAN PURUI Main Business Overview
13.6.5 HENAN PURUI Latest Developments
13.7 Albany Molecular Research
13.7.1 Albany Molecular Research Company Information
13.7.2 Albany Molecular Research Atropine Product Portfolios and Specifications
13.7.3 Albany Molecular Research Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Albany Molecular Research Main Business Overview
13.7.5 Albany Molecular Research Latest Developments
13.8 Alchem International
13.8.1 Alchem International Company Information
13.8.2 Alchem International Atropine Product Portfolios and Specifications
13.8.3 Alchem International Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Alchem International Main Business Overview
13.8.5 Alchem International Latest Developments
13.9 SAURAV CHEMICALS
13.9.1 SAURAV CHEMICALS Company Information
13.9.2 SAURAV CHEMICALS Atropine Product Portfolios and Specifications
13.9.3 SAURAV CHEMICALS Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 SAURAV CHEMICALS Main Business Overview
13.9.5 SAURAV CHEMICALS Latest Developments
13.10 Katsura Chemical
13.10.1 Katsura Chemical Company Information
13.10.2 Katsura Chemical Atropine Product Portfolios and Specifications
13.10.3 Katsura Chemical Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Katsura Chemical Main Business Overview
13.10.5 Katsura Chemical Latest Developments
13.11 Hangzhou Vega
13.11.1 Hangzhou Vega Company Information
13.11.2 Hangzhou Vega Atropine Product Portfolios and Specifications
13.11.3 Hangzhou Vega Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hangzhou Vega Main Business Overview
13.11.5 Hangzhou Vega Latest Developments
13.12 Wuhan senwayer century
13.12.1 Wuhan senwayer century Company Information
13.12.2 Wuhan senwayer century Atropine Product Portfolios and Specifications
13.12.3 Wuhan senwayer century Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Wuhan senwayer century Main Business Overview
13.12.5 Wuhan senwayer century Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Atropine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Atropine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Drop
Table 5. Major Players of Gel
Table 6. Global Atropine Sales byType (2020-2025) & (Kg)
Table 7. Global Atropine Sales Market Share byType (2020-2025)
Table 8. Global Atropine Revenue byType (2020-2025) & ($ million)
Table 9. Global Atropine Revenue Market Share byType (2020-2025)
Table 10. Global Atropine Sale Price byType (2020-2025) & (USD/Kg)
Table 11. Global Atropine Sale by Application (2020-2025) & (Kg)
Table 12. Global Atropine Sale Market Share by Application (2020-2025)
Table 13. Global Atropine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Atropine Revenue Market Share by Application (2020-2025)
Table 15. Global Atropine Sale Price by Application (2020-2025) & (USD/Kg)
Table 16. Global Atropine Sales by Company (2020-2025) & (Kg)
Table 17. Global Atropine Sales Market Share by Company (2020-2025)
Table 18. Global Atropine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Atropine Revenue Market Share by Company (2020-2025)
Table 20. Global Atropine Sale Price by Company (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Atropine Producing Area Distribution and Sales Area
Table 22. Players Atropine Products Offered
Table 23. Atropine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Atropine Sales by Geographic Region (2020-2025) & (Kg)
Table 27. Global Atropine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Atropine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Atropine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Atropine Sales by Country/Region (2020-2025) & (Kg)
Table 31. Global Atropine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Atropine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Atropine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Atropine Sales by Country (2020-2025) & (Kg)
Table 35. Americas Atropine Sales Market Share by Country (2020-2025)
Table 36. Americas Atropine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Atropine Sales byType (2020-2025) & (Kg)
Table 38. Americas Atropine Sales by Application (2020-2025) & (Kg)
Table 39. APAC Atropine Sales by Region (2020-2025) & (Kg)
Table 40. APAC Atropine Sales Market Share by Region (2020-2025)
Table 41. APAC Atropine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Atropine Sales byType (2020-2025) & (Kg)
Table 43. APAC Atropine Sales by Application (2020-2025) & (Kg)
Table 44. Europe Atropine Sales by Country (2020-2025) & (Kg)
Table 45. Europe Atropine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Atropine Sales byType (2020-2025) & (Kg)
Table 47. Europe Atropine Sales by Application (2020-2025) & (Kg)
Table 48. Middle East & Africa Atropine Sales by Country (2020-2025) & (Kg)
Table 49. Middle East & Africa Atropine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Atropine Sales byType (2020-2025) & (Kg)
Table 51. Middle East & Africa Atropine Sales by Application (2020-2025) & (Kg)
Table 52. Key Market Drivers & Growth Opportunities of Atropine
Table 53. Key Market Challenges & Risks of Atropine
Table 54. Key IndustryTrends of Atropine
Table 55. Atropine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Atropine Distributors List
Table 58. Atropine Customer List
Table 59. Global Atropine SalesForecast by Region (2026-2031) & (Kg)
Table 60. Global Atropine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Atropine SalesForecast by Country (2026-2031) & (Kg)
Table 62. Americas Atropine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Atropine SalesForecast by Region (2026-2031) & (Kg)
Table 64. APAC Atropine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Atropine SalesForecast by Country (2026-2031) & (Kg)
Table 66. Europe Atropine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Atropine SalesForecast by Country (2026-2031) & (Kg)
Table 68. Middle East & Africa Atropine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Atropine SalesForecast byType (2026-2031) & (Kg)
Table 70. Global Atropine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Atropine SalesForecast by Application (2026-2031) & (Kg)
Table 72. Global Atropine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. C?PHARMA Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 74. C?PHARMA Atropine Product Portfolios and Specifications
Table 75. C?PHARMA Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 76. C?PHARMA Main Business
Table 77. C?PHARMA Latest Developments
Table 78. RESONANCE LABORATORIES Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 79. RESONANCE LABORATORIES Atropine Product Portfolios and Specifications
Table 80. RESONANCE LABORATORIES Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. RESONANCE LABORATORIES Main Business
Table 82. RESONANCE LABORATORIES Latest Developments
Table 83. ROLABO OUTSOURCING Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 84. ROLABO OUTSOURCING Atropine Product Portfolios and Specifications
Table 85. ROLABO OUTSOURCING Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 86. ROLABO OUTSOURCING Main Business
Table 87. ROLABO OUTSOURCING Latest Developments
Table 88. Minsheng Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 89. Minsheng Atropine Product Portfolios and Specifications
Table 90. Minsheng Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 91. Minsheng Main Business
Table 92. Minsheng Latest Developments
Table 93. CR Double-Crane Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 94. CR Double-Crane Atropine Product Portfolios and Specifications
Table 95. CR Double-Crane Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. CR Double-Crane Main Business
Table 97. CR Double-Crane Latest Developments
Table 98. HENAN PURUI Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 99. HENAN PURUI Atropine Product Portfolios and Specifications
Table 100. HENAN PURUI Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 101. HENAN PURUI Main Business
Table 102. HENAN PURUI Latest Developments
Table 103. Albany Molecular Research Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 104. Albany Molecular Research Atropine Product Portfolios and Specifications
Table 105. Albany Molecular Research Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 106. Albany Molecular Research Main Business
Table 107. Albany Molecular Research Latest Developments
Table 108. Alchem International Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 109. Alchem International Atropine Product Portfolios and Specifications
Table 110. Alchem International Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 111. Alchem International Main Business
Table 112. Alchem International Latest Developments
Table 113. SAURAV CHEMICALS Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 114. SAURAV CHEMICALS Atropine Product Portfolios and Specifications
Table 115. SAURAV CHEMICALS Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 116. SAURAV CHEMICALS Main Business
Table 117. SAURAV CHEMICALS Latest Developments
Table 118. Katsura Chemical Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 119. Katsura Chemical Atropine Product Portfolios and Specifications
Table 120. Katsura Chemical Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 121. Katsura Chemical Main Business
Table 122. Katsura Chemical Latest Developments
Table 123. Hangzhou Vega Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 124. Hangzhou Vega Atropine Product Portfolios and Specifications
Table 125. Hangzhou Vega Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 126. Hangzhou Vega Main Business
Table 127. Hangzhou Vega Latest Developments
Table 128. Wuhan senwayer century Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 129. Wuhan senwayer century Atropine Product Portfolios and Specifications
Table 130. Wuhan senwayer century Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 131. Wuhan senwayer century Main Business
Table 132. Wuhan senwayer century Latest Developments
LIST OFFIGURES
Figure 1. Picture of Atropine
Figure 2. Atropine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atropine Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Atropine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Atropine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Atropine Sales Market Share by Country/Region (2024)
Figure 10. Atropine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Drop
Figure 13. Product Picture of Gel
Figure 14. Global Atropine Sales Market Share byType in 2025
Figure 15. Global Atropine Revenue Market Share byType (2020-2025)
Figure 16. Atropine Consumed in Gastrointestinal
Figure 17. Global Atropine Market: Gastrointestinal (2020-2025) & (Kg)
Figure 18. Atropine Consumed in Ophthalmology
Figure 19. Global Atropine Market: Ophthalmology (2020-2025) & (Kg)
Figure 20. Atropine Consumed in Other
Figure 21. Global Atropine Market: Other (2020-2025) & (Kg)
Figure 22. Global Atropine Sale Market Share by Application (2024)
Figure 23. Global Atropine Revenue Market Share by Application in 2025
Figure 24. Atropine Sales by Company in 2025 (Kg)
Figure 25. Global Atropine Sales Market Share by Company in 2025
Figure 26. Atropine Revenue by Company in 2025 ($ millions)
Figure 27. Global Atropine Revenue Market Share by Company in 2025
Figure 28. Global Atropine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Atropine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Atropine Sales 2020-2025 (Kg)
Figure 31. Americas Atropine Revenue 2020-2025 ($ millions)
Figure 32. APAC Atropine Sales 2020-2025 (Kg)
Figure 33. APAC Atropine Revenue 2020-2025 ($ millions)
Figure 34. Europe Atropine Sales 2020-2025 (Kg)
Figure 35. Europe Atropine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Atropine Sales 2020-2025 (Kg)
Figure 37. Middle East & Africa Atropine Revenue 2020-2025 ($ millions)
Figure 38. Americas Atropine Sales Market Share by Country in 2025
Figure 39. Americas Atropine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Atropine Sales Market Share byType (2020-2025)
Figure 41. Americas Atropine Sales Market Share by Application (2020-2025)
Figure 42. United States Atropine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Atropine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Atropine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Atropine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Atropine Sales Market Share by Region in 2025
Figure 47. APAC Atropine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Atropine Sales Market Share byType (2020-2025)
Figure 49. APAC Atropine Sales Market Share by Application (2020-2025)
Figure 50. China Atropine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Atropine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Atropine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Atropine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Atropine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Atropine Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Atropine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Atropine Sales Market Share by Country in 2025
Figure 58. Europe Atropine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Atropine Sales Market Share byType (2020-2025)
Figure 60. Europe Atropine Sales Market Share by Application (2020-2025)
Figure 61. Germany Atropine Revenue Growth 2020-2025 ($ millions)
Figure 62.France Atropine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Atropine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Atropine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Atropine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Atropine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Atropine Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Atropine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Atropine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Atropine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Atropine Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Atropine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Atropine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Atropine in 2025
Figure 75. Manufacturing Process Analysis of Atropine
Figure 76. Industry Chain Structure of Atropine
Figure 77. Channels of Distribution
Figure 78. Global Atropine Sales MarketForecast by Region (2026-2031)
Figure 79. Global Atropine Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Atropine Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Atropine Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Atropine Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Atropine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Atropine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Atropine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Atropine by Country/Region, 2020, 2024 & 2031
2.2 Atropine Segment by Type
2.2.1 Injection
2.2.2 Drop
2.2.3 Gel
2.3 Atropine Sales by Type
2.3.1 Global Atropine Sales Market Share by Type (2020-2025)
2.3.2 Global Atropine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Atropine Sale Price by Type (2020-2025)
2.4 Atropine Segment by Application
2.4.1 Gastrointestinal
2.4.2 Ophthalmology
2.4.3 Other
2.5 Atropine Sales by Application
2.5.1 Global Atropine Sale Market Share by Application (2020-2025)
2.5.2 Global Atropine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Atropine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Atropine Breakdown Data by Company
3.1.1 Global Atropine Annual Sales by Company (2020-2025)
3.1.2 Global Atropine Sales Market Share by Company (2020-2025)
3.2 Global Atropine Annual Revenue by Company (2020-2025)
3.2.1 Global Atropine Revenue by Company (2020-2025)
3.2.2 Global Atropine Revenue Market Share by Company (2020-2025)
3.3 Global Atropine Sale Price by Company
3.4 Key Manufacturers Atropine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Atropine Product Location Distribution
3.4.2 Players Atropine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ATROPINE BY GEOGRAPHIC REGION
4.1 World Historic Atropine Market Size by Geographic Region (2020-2025)
4.1.1 Global Atropine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Atropine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Atropine Market Size by Country/Region (2020-2025)
4.2.1 Global Atropine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Atropine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Atropine Sales Growth
4.4 APAC Atropine Sales Growth
4.5 Europe Atropine Sales Growth
4.6 Middle East & Africa Atropine Sales Growth
5 AMERICAS
5.1 Americas Atropine Sales by Country
5.1.1 Americas Atropine Sales by Country (2020-2025)
5.1.2 Americas Atropine Revenue by Country (2020-2025)
5.2 Americas Atropine Sales by Type (2020-2025)
5.3 Americas Atropine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Atropine Sales by Region
6.1.1 APAC Atropine Sales by Region (2020-2025)
6.1.2 APAC Atropine Revenue by Region (2020-2025)
6.2 APAC Atropine Sales by Type (2020-2025)
6.3 APAC Atropine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Atropine by Country
7.1.1 Europe Atropine Sales by Country (2020-2025)
7.1.2 Europe Atropine Revenue by Country (2020-2025)
7.2 Europe Atropine Sales by Type (2020-2025)
7.3 Europe Atropine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Atropine by Country
8.1.1 Middle East & Africa Atropine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Atropine Revenue by Country (2020-2025)
8.2 Middle East & Africa Atropine Sales by Type (2020-2025)
8.3 Middle East & Africa Atropine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atropine
10.3 Manufacturing Process Analysis of Atropine
10.4 Industry Chain Structure of Atropine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Atropine Distributors
11.3 Atropine Customer
12 WORLD FORECAST REVIEW FOR ATROPINE BY GEOGRAPHIC REGION
12.1 Global Atropine Market Size Forecast by Region
12.1.1 Global Atropine Forecast by Region (2026-2031)
12.1.2 Global Atropine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Atropine Forecast by Type (2026-2031)
12.7 Global Atropine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 C?PHARMA
13.1.1 C?PHARMA Company Information
13.1.2 C?PHARMA Atropine Product Portfolios and Specifications
13.1.3 C?PHARMA Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 C?PHARMA Main Business Overview
13.1.5 C?PHARMA Latest Developments
13.2 RESONANCE LABORATORIES
13.2.1 RESONANCE LABORATORIES Company Information
13.2.2 RESONANCE LABORATORIES Atropine Product Portfolios and Specifications
13.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 RESONANCE LABORATORIES Main Business Overview
13.2.5 RESONANCE LABORATORIES Latest Developments
13.3 ROLABO OUTSOURCING
13.3.1 ROLABO OUTSOURCING Company Information
13.3.2 ROLABO OUTSOURCING Atropine Product Portfolios and Specifications
13.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ROLABO OUTSOURCING Main Business Overview
13.3.5 ROLABO OUTSOURCING Latest Developments
13.4 Minsheng
13.4.1 Minsheng Company Information
13.4.2 Minsheng Atropine Product Portfolios and Specifications
13.4.3 Minsheng Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Minsheng Main Business Overview
13.4.5 Minsheng Latest Developments
13.5 CR Double-Crane
13.5.1 CR Double-Crane Company Information
13.5.2 CR Double-Crane Atropine Product Portfolios and Specifications
13.5.3 CR Double-Crane Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CR Double-Crane Main Business Overview
13.5.5 CR Double-Crane Latest Developments
13.6 HENAN PURUI
13.6.1 HENAN PURUI Company Information
13.6.2 HENAN PURUI Atropine Product Portfolios and Specifications
13.6.3 HENAN PURUI Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HENAN PURUI Main Business Overview
13.6.5 HENAN PURUI Latest Developments
13.7 Albany Molecular Research
13.7.1 Albany Molecular Research Company Information
13.7.2 Albany Molecular Research Atropine Product Portfolios and Specifications
13.7.3 Albany Molecular Research Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Albany Molecular Research Main Business Overview
13.7.5 Albany Molecular Research Latest Developments
13.8 Alchem International
13.8.1 Alchem International Company Information
13.8.2 Alchem International Atropine Product Portfolios and Specifications
13.8.3 Alchem International Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Alchem International Main Business Overview
13.8.5 Alchem International Latest Developments
13.9 SAURAV CHEMICALS
13.9.1 SAURAV CHEMICALS Company Information
13.9.2 SAURAV CHEMICALS Atropine Product Portfolios and Specifications
13.9.3 SAURAV CHEMICALS Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 SAURAV CHEMICALS Main Business Overview
13.9.5 SAURAV CHEMICALS Latest Developments
13.10 Katsura Chemical
13.10.1 Katsura Chemical Company Information
13.10.2 Katsura Chemical Atropine Product Portfolios and Specifications
13.10.3 Katsura Chemical Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Katsura Chemical Main Business Overview
13.10.5 Katsura Chemical Latest Developments
13.11 Hangzhou Vega
13.11.1 Hangzhou Vega Company Information
13.11.2 Hangzhou Vega Atropine Product Portfolios and Specifications
13.11.3 Hangzhou Vega Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hangzhou Vega Main Business Overview
13.11.5 Hangzhou Vega Latest Developments
13.12 Wuhan senwayer century
13.12.1 Wuhan senwayer century Company Information
13.12.2 Wuhan senwayer century Atropine Product Portfolios and Specifications
13.12.3 Wuhan senwayer century Atropine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Wuhan senwayer century Main Business Overview
13.12.5 Wuhan senwayer century Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Atropine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Atropine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Drop
Table 5. Major Players of Gel
Table 6. Global Atropine Sales byType (2020-2025) & (Kg)
Table 7. Global Atropine Sales Market Share byType (2020-2025)
Table 8. Global Atropine Revenue byType (2020-2025) & ($ million)
Table 9. Global Atropine Revenue Market Share byType (2020-2025)
Table 10. Global Atropine Sale Price byType (2020-2025) & (USD/Kg)
Table 11. Global Atropine Sale by Application (2020-2025) & (Kg)
Table 12. Global Atropine Sale Market Share by Application (2020-2025)
Table 13. Global Atropine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Atropine Revenue Market Share by Application (2020-2025)
Table 15. Global Atropine Sale Price by Application (2020-2025) & (USD/Kg)
Table 16. Global Atropine Sales by Company (2020-2025) & (Kg)
Table 17. Global Atropine Sales Market Share by Company (2020-2025)
Table 18. Global Atropine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Atropine Revenue Market Share by Company (2020-2025)
Table 20. Global Atropine Sale Price by Company (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Atropine Producing Area Distribution and Sales Area
Table 22. Players Atropine Products Offered
Table 23. Atropine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Atropine Sales by Geographic Region (2020-2025) & (Kg)
Table 27. Global Atropine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Atropine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Atropine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Atropine Sales by Country/Region (2020-2025) & (Kg)
Table 31. Global Atropine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Atropine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Atropine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Atropine Sales by Country (2020-2025) & (Kg)
Table 35. Americas Atropine Sales Market Share by Country (2020-2025)
Table 36. Americas Atropine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Atropine Sales byType (2020-2025) & (Kg)
Table 38. Americas Atropine Sales by Application (2020-2025) & (Kg)
Table 39. APAC Atropine Sales by Region (2020-2025) & (Kg)
Table 40. APAC Atropine Sales Market Share by Region (2020-2025)
Table 41. APAC Atropine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Atropine Sales byType (2020-2025) & (Kg)
Table 43. APAC Atropine Sales by Application (2020-2025) & (Kg)
Table 44. Europe Atropine Sales by Country (2020-2025) & (Kg)
Table 45. Europe Atropine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Atropine Sales byType (2020-2025) & (Kg)
Table 47. Europe Atropine Sales by Application (2020-2025) & (Kg)
Table 48. Middle East & Africa Atropine Sales by Country (2020-2025) & (Kg)
Table 49. Middle East & Africa Atropine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Atropine Sales byType (2020-2025) & (Kg)
Table 51. Middle East & Africa Atropine Sales by Application (2020-2025) & (Kg)
Table 52. Key Market Drivers & Growth Opportunities of Atropine
Table 53. Key Market Challenges & Risks of Atropine
Table 54. Key IndustryTrends of Atropine
Table 55. Atropine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Atropine Distributors List
Table 58. Atropine Customer List
Table 59. Global Atropine SalesForecast by Region (2026-2031) & (Kg)
Table 60. Global Atropine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Atropine SalesForecast by Country (2026-2031) & (Kg)
Table 62. Americas Atropine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Atropine SalesForecast by Region (2026-2031) & (Kg)
Table 64. APAC Atropine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Atropine SalesForecast by Country (2026-2031) & (Kg)
Table 66. Europe Atropine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Atropine SalesForecast by Country (2026-2031) & (Kg)
Table 68. Middle East & Africa Atropine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Atropine SalesForecast byType (2026-2031) & (Kg)
Table 70. Global Atropine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Atropine SalesForecast by Application (2026-2031) & (Kg)
Table 72. Global Atropine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. C?PHARMA Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 74. C?PHARMA Atropine Product Portfolios and Specifications
Table 75. C?PHARMA Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 76. C?PHARMA Main Business
Table 77. C?PHARMA Latest Developments
Table 78. RESONANCE LABORATORIES Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 79. RESONANCE LABORATORIES Atropine Product Portfolios and Specifications
Table 80. RESONANCE LABORATORIES Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. RESONANCE LABORATORIES Main Business
Table 82. RESONANCE LABORATORIES Latest Developments
Table 83. ROLABO OUTSOURCING Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 84. ROLABO OUTSOURCING Atropine Product Portfolios and Specifications
Table 85. ROLABO OUTSOURCING Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 86. ROLABO OUTSOURCING Main Business
Table 87. ROLABO OUTSOURCING Latest Developments
Table 88. Minsheng Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 89. Minsheng Atropine Product Portfolios and Specifications
Table 90. Minsheng Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 91. Minsheng Main Business
Table 92. Minsheng Latest Developments
Table 93. CR Double-Crane Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 94. CR Double-Crane Atropine Product Portfolios and Specifications
Table 95. CR Double-Crane Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. CR Double-Crane Main Business
Table 97. CR Double-Crane Latest Developments
Table 98. HENAN PURUI Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 99. HENAN PURUI Atropine Product Portfolios and Specifications
Table 100. HENAN PURUI Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 101. HENAN PURUI Main Business
Table 102. HENAN PURUI Latest Developments
Table 103. Albany Molecular Research Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 104. Albany Molecular Research Atropine Product Portfolios and Specifications
Table 105. Albany Molecular Research Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 106. Albany Molecular Research Main Business
Table 107. Albany Molecular Research Latest Developments
Table 108. Alchem International Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 109. Alchem International Atropine Product Portfolios and Specifications
Table 110. Alchem International Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 111. Alchem International Main Business
Table 112. Alchem International Latest Developments
Table 113. SAURAV CHEMICALS Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 114. SAURAV CHEMICALS Atropine Product Portfolios and Specifications
Table 115. SAURAV CHEMICALS Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 116. SAURAV CHEMICALS Main Business
Table 117. SAURAV CHEMICALS Latest Developments
Table 118. Katsura Chemical Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 119. Katsura Chemical Atropine Product Portfolios and Specifications
Table 120. Katsura Chemical Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 121. Katsura Chemical Main Business
Table 122. Katsura Chemical Latest Developments
Table 123. Hangzhou Vega Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 124. Hangzhou Vega Atropine Product Portfolios and Specifications
Table 125. Hangzhou Vega Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 126. Hangzhou Vega Main Business
Table 127. Hangzhou Vega Latest Developments
Table 128. Wuhan senwayer century Basic Information, Atropine Manufacturing Base, Sales Area and Its Competitors
Table 129. Wuhan senwayer century Atropine Product Portfolios and Specifications
Table 130. Wuhan senwayer century Atropine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 131. Wuhan senwayer century Main Business
Table 132. Wuhan senwayer century Latest Developments
LIST OFFIGURES
Figure 1. Picture of Atropine
Figure 2. Atropine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atropine Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Atropine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Atropine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Atropine Sales Market Share by Country/Region (2024)
Figure 10. Atropine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Drop
Figure 13. Product Picture of Gel
Figure 14. Global Atropine Sales Market Share byType in 2025
Figure 15. Global Atropine Revenue Market Share byType (2020-2025)
Figure 16. Atropine Consumed in Gastrointestinal
Figure 17. Global Atropine Market: Gastrointestinal (2020-2025) & (Kg)
Figure 18. Atropine Consumed in Ophthalmology
Figure 19. Global Atropine Market: Ophthalmology (2020-2025) & (Kg)
Figure 20. Atropine Consumed in Other
Figure 21. Global Atropine Market: Other (2020-2025) & (Kg)
Figure 22. Global Atropine Sale Market Share by Application (2024)
Figure 23. Global Atropine Revenue Market Share by Application in 2025
Figure 24. Atropine Sales by Company in 2025 (Kg)
Figure 25. Global Atropine Sales Market Share by Company in 2025
Figure 26. Atropine Revenue by Company in 2025 ($ millions)
Figure 27. Global Atropine Revenue Market Share by Company in 2025
Figure 28. Global Atropine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Atropine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Atropine Sales 2020-2025 (Kg)
Figure 31. Americas Atropine Revenue 2020-2025 ($ millions)
Figure 32. APAC Atropine Sales 2020-2025 (Kg)
Figure 33. APAC Atropine Revenue 2020-2025 ($ millions)
Figure 34. Europe Atropine Sales 2020-2025 (Kg)
Figure 35. Europe Atropine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Atropine Sales 2020-2025 (Kg)
Figure 37. Middle East & Africa Atropine Revenue 2020-2025 ($ millions)
Figure 38. Americas Atropine Sales Market Share by Country in 2025
Figure 39. Americas Atropine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Atropine Sales Market Share byType (2020-2025)
Figure 41. Americas Atropine Sales Market Share by Application (2020-2025)
Figure 42. United States Atropine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Atropine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Atropine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Atropine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Atropine Sales Market Share by Region in 2025
Figure 47. APAC Atropine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Atropine Sales Market Share byType (2020-2025)
Figure 49. APAC Atropine Sales Market Share by Application (2020-2025)
Figure 50. China Atropine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Atropine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Atropine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Atropine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Atropine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Atropine Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Atropine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Atropine Sales Market Share by Country in 2025
Figure 58. Europe Atropine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Atropine Sales Market Share byType (2020-2025)
Figure 60. Europe Atropine Sales Market Share by Application (2020-2025)
Figure 61. Germany Atropine Revenue Growth 2020-2025 ($ millions)
Figure 62.France Atropine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Atropine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Atropine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Atropine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Atropine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Atropine Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Atropine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Atropine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Atropine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Atropine Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Atropine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Atropine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Atropine in 2025
Figure 75. Manufacturing Process Analysis of Atropine
Figure 76. Industry Chain Structure of Atropine
Figure 77. Channels of Distribution
Figure 78. Global Atropine Sales MarketForecast by Region (2026-2031)
Figure 79. Global Atropine Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Atropine Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Atropine Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Atropine Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Atropine Revenue Market ShareForecast by Application (2026-2031)
